Skip to content
MarketScale
‹ Back to IndustriesHealthcare

AI Adoption in Healthcare is Growing. Healthcare Pros Need To Differentiate Between AI, Automation, and Unfounded Hype.

According to a recent survey from healthcare advisory firm Sage Growth Partners, a staggering 90% of hospitals now have the power of artificial intelligence on their radar, in varying stages of adoption, to revolutionize patient care and streamline operations. AI adoption in healthcare organizations is poised to achieve better, more equitable, and affordable patient outcomes….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

According to a recent survey from healthcare advisory firm Sage Growth Partners, a staggering 90% of hospitals now have the power of artificial intelligence on their radar, in varying stages of adoption, to revolutionize patient care and streamline operations. AI adoption in healthcare organizations is poised to achieve better, more equitable, and affordable patient outcomes. For example, machine learning in medical diagnostics has already shown significant potential to improve the accuracy and efficiency of diagnoses.

Healthcare has increasingly become the ultimate proving ground for AI technology, with applications ranging from predictive analytics to personalized medicine. Experts believe that AI and ML can revolutionize the industry by identifying patterns in complex data, automating repetitive tasks, and enabling more informed decision-making. It’s becoming more and more evident, though, that this technology ecosystem can come with a lot of hype, and that hype can cloud important judgment and understandings around different tech in the artificial intelligence ecosystem. Christina Cussimanio, SVP of Marketing at AGS Health, highlights the growing role of AI adoption in healthcare organizations, emphasizing the distinction between AI and automation while illustrating AI’s potential to transform revenue cycle management.

Christina’s Thoughts

“Did you know more than 80% of healthcare organizations report they’ve already implemented an AI strategy? AI is addressing some of healthcare organizations’ biggest pain points, increasing revenue capture, and helping those early adopters achieve revenue integrity. With that being said, AI and automation are terms that are often used interchangeably.

However, the differences are not as subtle as they appear. While automation’s about setting up bots to follow a set of predefined rules, AI is about setting up cognitive bots to make their own decisions. AI is made up of different technologies that allow the machine to act at the human level of intelligence, a process that requires learning from past experiences and self-correction to make decisions and reach conclusions. A good example of AI is the ability to predict denials by identifying and assessing attributes commonly found in at-risk claims before or prior to submission. You can learn more about the role of AI in RCM operations by reading our white paper, artificial intelligence for RCM, separating hype from reality.”

Article Written by Azam Saghir.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

OpenAI’s ChatGPT for Healthcare is getting wired into Epic

OpenAI’s ChatGPT for Healthcare is getting wired into Epic

ChatGPT for Healthcare can now read from Epic. UCSF Health is piloting the read-only integration, according to Fierce Healthcare and Becker’s Hospital Review. For CIOs, the work is permissions, auditability, and clinical validation in Epic workflows.

  • 01The “read-only” label doesn’t remove governance work, it moves it to permissions mapping, audit logs, and connector scope design inside Epic-supported workflows.
  • 02OpenAI’s published clinician review results (99.1% rated safe across 4,363 ratings) are a useful benchmark, but they still need local validation on your own note templates, meds workflows, and specialty mix.

Sep 7, 2026

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512